Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1998 Dec;35(12):1009–1013. doi: 10.1136/jmg.35.12.1009

The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy.

R de Franchis 1, A Buoninconti 1, C Mandato 1, A Pepe 1, M P Sperandeo 1, R Del Gado 1, V Capra 1, E Salvaggio 1, G Andria 1, P Mastroiacovo 1
PMCID: PMC1051513  PMID: 9863598

Abstract

OBJECTIVE: To estimate the risk for spina bifida associated with the common mutation C677T of the MTHFR gene in a country with a relatively low prevalence of NTDs. DESIGN: Case-control study. SUBJECTS: Cases: 203 living patients affected with spina bifida (173 myelomeningocele and 30 lipomeningocele); controls: 583 subjects (306 young adults and 277 unselected newborns) from northern and central-southern Italy. SETTING: Cases: three spina bifida centres; young adult controls: DNA banks; newborn controls: regional neonatal screening centres. MAIN OUTCOME MEASURES: Prevalence of the C677T genotypes in cases and controls by place of birth; odds ratios for spina bifida and estimated attributable fraction. RESULTS: The prevalence of T/T, T/C, and C/C genotype was 16.6%, 53.7%, and 29.7% in controls and 25.6%, 43.8%, and 30.6% in cases, respectively. We found no differences between type of defect or place of birth. The odds ratio for spina bifida associated with the T/T genotype v C/C plus T/C was 1.73 (95% CI 1.15, 2.59) and the corresponding attributable fraction was 10.8%. No increased risk was found for heterozygous patients (OR=0.79, 95% CI 0.53-1.18). CONCLUSION: This study, as well as the meta-analysis we updated, shows that homozygosity for the MTHFR C677T mutation is a moderate risk factor in Europe, and even in Italy where there is a relatively low prevalence of spina bifida. The estimated attributable fraction associated with this risk factor explains only a small proportion of cases preventable by periconceptional folic acid supplementation. Thus, other genes involved in folate-homocysteine metabolism, their interaction, and the interaction between genetic and environmental factors should be investigated further.

Full text

PDF
1009

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry G. T., Nissim I., Lin Z., Mazur A. T., Gibson J. B., Segal S. Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet. 1995 Oct 21;346(8982):1073–1074. doi: 10.1016/s0140-6736(95)91745-4. [DOI] [PubMed] [Google Scholar]
  2. Bjørke-Monsen A. L., Ueland P. M., Schneede J., Vollset S. E., Refsum H. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. QJM. 1997 Sep;90(9):593–596. doi: 10.1093/qjmed/90.9.593. [DOI] [PubMed] [Google Scholar]
  3. Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J., den Heijer M., Kluijtmans L. A., van den Heuvel L. P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 May;10(1):111–113. doi: 10.1038/ng0595-111. [DOI] [PubMed] [Google Scholar]
  4. Grandone E., Margaglione M., Colaizzo D., Cappucci G., Paladini D., Martinelli P., Montanaro S., Pavone G., Di Minno G. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost. 1997 Jun;77(6):1052–1054. [PubMed] [Google Scholar]
  5. Jacob R. A., Wu M. M., Henning S. M., Swendseid M. E. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J Nutr. 1994 Jul;124(7):1072–1080. doi: 10.1093/jn/124.7.1072. [DOI] [PubMed] [Google Scholar]
  6. Matsushita S., Muramatsu T., Arai H., Matsui T., Higuchi S. The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population. Am J Hum Genet. 1997 Dec;61(6):1459–1460. doi: 10.1086/301640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Miettinen O. S. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974 May;99(5):325–332. doi: 10.1093/oxfordjournals.aje.a121617. [DOI] [PubMed] [Google Scholar]
  8. Mills J. L., McPartlin J. M., Kirke P. N., Lee Y. J., Conley M. R., Weir D. G., Scott J. M. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995 Jan 21;345(8943):149–151. doi: 10.1016/s0140-6736(95)90165-5. [DOI] [PubMed] [Google Scholar]
  9. Mornet E., Muller F., Lenvoisé-Furet A., Delezoide A. L., Col J. Y., Simon-Bouy B., Serre J. L. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet. 1997 Oct;100(5-6):512–514. doi: 10.1007/s004390050544. [DOI] [PubMed] [Google Scholar]
  10. Ou C. Y., Stevenson R. E., Brown V. K., Schwartz C. E., Allen W. P., Khoury M. J., Rozen R., Oakley G. P., Jr, Adams M. J., Jr 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet. 1996 Jun 28;63(4):610–614. doi: 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  11. Papapetrou C., Lynch S. A., Burn J., Edwards Y. H. Methylenetetrahydrofolate reductase and neural tube defects. Lancet. 1996 Jul 6;348(9019):58–58. doi: 10.1016/s0140-6736(05)64382-6. [DOI] [PubMed] [Google Scholar]
  12. Posey D. L., Khoury M. J., Mulinare J., Adams M. J., Jr, Ou C. Y. Is mutated MTHFR a risk factor for neural tube defects? Lancet. 1996 Mar 9;347(9002):686–687. [PubMed] [Google Scholar]
  13. Ramsbottom D., Scott J. M., Molloy A., Weir D. G., Kirke P. N., Mills J. L., Gallagher P. M., Whitehead A. S. Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet. 1997 Jan;51(1):39–42. doi: 10.1111/j.1399-0004.1997.tb02412.x. [DOI] [PubMed] [Google Scholar]
  14. Sacchi E., Tagliabue L., Duca F., Mannucci P. M. High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost. 1997 Aug;78(2):963–964. [PubMed] [Google Scholar]
  15. Steegers-Theunissen R. P., Boers G. H., Trijbels F. J., Finkelstein J. D., Blom H. J., Thomas C. M., Borm G. F., Wouters M. G., Eskes T. K. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994 Dec;43(12):1475–1480. doi: 10.1016/0026-0495(94)90004-3. [DOI] [PubMed] [Google Scholar]
  16. Tosetto A., Missiaglia E., Frezzato M., Rodeghiero F. The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism. Br J Haematol. 1997 Jun;97(4):804–806. doi: 10.1046/j.1365-2141.1997.1422957.x. [DOI] [PubMed] [Google Scholar]
  17. Ubbink J. B. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia. J Inherit Metab Dis. 1997 Jun;20(2):316–325. doi: 10.1023/a:1005329427711. [DOI] [PubMed] [Google Scholar]
  18. Wald N. J. Folic acid and neural tube defects: the current evidence and implications for prevention. Ciba Found Symp. 1994;181:192–211. doi: 10.1002/9780470514559.ch12. [DOI] [PubMed] [Google Scholar]
  19. Whitehead A. S., Gallagher P., Mills J. L., Kirke P. N., Burke H., Molloy A. M., Weir D. G., Shields D. C., Scott J. M. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM. 1995 Nov;88(11):763–766. [PubMed] [Google Scholar]
  20. Wilcken D. E. MTHFR 677C-->T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet. 1997 Aug 30;350(9078):603–604. doi: 10.1016/S0140-6736(05)63320-X. [DOI] [PubMed] [Google Scholar]
  21. van der Put N. M., Steegers-Theunissen R. P., Frosst P., Trijbels F. J., Eskes T. K., van den Heuvel L. P., Mariman E. C., den Heyer M., Rozen R., Blom H. J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995 Oct 21;346(8982):1070–1071. doi: 10.1016/s0140-6736(95)91743-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES